These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 14577595)
1. Membrane-bound alkaline phosphatase gene induces antitumor effect by G2/M arrest in etoposide phosphate-treated cancer cells. Kim KY; Cho YJ; Jeon GA; Ryu PD; Myeong JN Mol Cell Biochem; 2003 Oct; 252(1-2):213-21. PubMed ID: 14577595 [TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Senter PD; Saulnier MG; Schreiber GJ; Hirschberg DL; Brown JP; Hellström I; Hellström KE Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4842-6. PubMed ID: 3387440 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates. Senter PD; Schreiber GJ; Hirschberg DL; Ashe SA; Hellström KE; Hellström I Cancer Res; 1989 Nov; 49(21):5789-92. PubMed ID: 2790791 [TBL] [Abstract][Full Text] [Related]
4. Alkaline phosphatase-triggered assembly of etoposide enhances its anticancer effect. Kiran S; Hai Z; Ding Z; Wang L; Liu Y; Zhang H; Liang G Chem Commun (Camb); 2018 Feb; 54(15):1853-1856. PubMed ID: 29387836 [TBL] [Abstract][Full Text] [Related]
5. Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate. Haisma HJ; Boven E; van Muijen M; De Vries R; Pinedo HM Cancer Immunol Immunother; 1992; 34(5):343-8. PubMed ID: 1540981 [TBL] [Abstract][Full Text] [Related]
6. Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging. Srinivas R; Satterlee A; Wang Y; Zhang Y; Wang Y; Huang L Nanoscale; 2015 Nov; 7(44):18542-18551. PubMed ID: 26489694 [TBL] [Abstract][Full Text] [Related]
7. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study. Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232 [TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer. Soni N; Meropol NJ; Pendyala L; Noel D; Schacter LP; Gunton KE; Creaven PJ J Clin Oncol; 1997 Feb; 15(2):766-72. PubMed ID: 9053503 [TBL] [Abstract][Full Text] [Related]
9. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097 [TBL] [Abstract][Full Text] [Related]
10. Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile. de Jong RS; Slijfer EA; Uges DR; Mulder NH; de Vries EG Br J Cancer; 1997; 76(11):1480-3. PubMed ID: 9400945 [TBL] [Abstract][Full Text] [Related]
11. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death. Sleiman RJ; Stewart BW Clin Cancer Res; 2000 Sep; 6(9):3756-65. PubMed ID: 10999770 [TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Jin ZH; Kurosu T; Yamaguchi M; Arai A; Miura O Oncogene; 2005 Mar; 24(12):1973-81. PubMed ID: 15674326 [TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and expression of a cDNA encoding the membrane-associated rat intestinal alkaline phosphatase. Lowe M; Strauss AW; Alpers R; Seetharam S; Alpers DH Biochim Biophys Acta; 1990 Feb; 1037(2):170-7. PubMed ID: 2155025 [TBL] [Abstract][Full Text] [Related]
14. Etoposide phosphate, the water soluble prodrug of etoposide. Witterland AH; Koks CH; Beijnen JH Pharm World Sci; 1996 Oct; 18(5):163-70. PubMed ID: 8933576 [TBL] [Abstract][Full Text] [Related]
15. Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: implications for gene therapy. Skladanowski A; Larsen AK Cancer Res; 1997 Mar; 57(5):818-23. PubMed ID: 9041178 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression. Braybrooke JP; Levitt NC; Joel S; Davis T; Madhusudan S; Turley H; Wilner S; Harris AL; Talbot DC Clin Cancer Res; 2003 Oct; 9(13):4682-8. PubMed ID: 14581337 [TBL] [Abstract][Full Text] [Related]
17. Detection of endogenous and antibody-conjugated alkaline phosphatase with ELF-97 phosphate in multicolor flow cytometry applications. Telford W; Cox W; Singer V Cytometry; 2001 Feb; 43(2):117-25. PubMed ID: 11169576 [TBL] [Abstract][Full Text] [Related]
18. Second generation analogs of etoposide and mitomycin C. Doyle TW; Vyas DM Cancer Treat Rev; 1990 Sep; 17(2-3):127-31. PubMed ID: 2125529 [TBL] [Abstract][Full Text] [Related]
20. Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa x fibroblast cell hybrids. Latham KM; Stanbridge EJ Cancer Res; 1992 Feb; 52(3):616-22. PubMed ID: 1732049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]